Skip to main content

Table 1 Clinicopathologic characteristics of patients with NSCLC who had undergone complete resection

From: Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer

Variables

No. of subjects (n = 429)

Gender

 

   Male

324 (75.5%)

   Female

105 (24.5%)

Age (median, years)

62 (range: 26-81)

Tumor size (median, cm)

3.8 (range: 0.8-20)

Type of surgical resection*

 

   Pneumonectomy

70 (16.4%)

   Bilobectomy

32 (7.5%)

   Lobectomy

319 (74.7%)

   Limited resection

6 (1.4%)

Clinical stage

 

   I

221 (51.5%)

   II

102 (23.8%)

   III

106 (24.7%)

Adjuvant therapy**

 

   Chemotherapy only

68 (15.9%)

   Radiotherapy only

104 (24.2%)

   Neither

184 (42.9%)

   Both

71 (16.6%)

Median follow-up period (mean ± SD, months)

65.8(56.3 ± 33.9)

Recurrent cases (recurrence rate)

170 (39.6%)

  1. * Information on the type of surgical resection was not available in two cases.
  2. ** Information on radiotherapy was not available in two of the cases treated with chemotherapy.